The Russian Health Ministry has suspended orders of the country’s second coronavirus vaccine due to low demand nationwide, the Vedomosti business daily reported Tuesday. Citing the federal health watchdog’s drug …
The EpiVacCorona-N coronavirus vaccine will be released into civil circulation in the near future, Tatiana Nepomnyashchikh, a deputy head of the Vector State Research Center of Virology and Biotechnology, said. "EpiVacCorona-N has …
The Russian Health Ministry has registered the EpiVacCorona-N coronavirus vaccine, as seen from the state register of medicinal products. EpiVacCorona-N was developed by the Vector Center of Russian public health and consumer protection …
The EpiVacCorona vaccine is effective against all dangerous mutations of the novel coronavirus, including the Delta and Delta Plus strains, head of the Vector State Research Center of Virology and Biotechnology Rinat Maksyutov said on …
The Mexican government has contacted Russia’s State Research Center of Virology and Biotechnology "Vector" to discuss the potential deliveries of the EpiVacCorona vaccine developed by the center, Mexico’s Foreign Secretary …
Just one day will be enough to update Russia's EpiVacCorona vaccine to ensure protection against new mutations of the coronavirus, the Russian State Research Center of Virology and Biotechnology Vector's General Director …
Russia’s vaccine EpiVacCorona is effective against the British and South African mutations of the novel coronavirus, the chief of the Yekaterinburg Research Institute of Viral Infections Vector, Alexander Semyonov said on the Vesti FM radio …
Around 200,000 doses of the EpiVacCorona coronavirus vaccine have been made available for general use in Russia, deputy head of the vaccine developer, Vector Center, Tatyana Nepomnyashchikh said in an interview with RT Tuesday. …
Russia’s EpiVacCorona coronavirus vaccine is safe and effective, according to the results of clinical trials published in the Infection and Immunity journal, the Federal Service for Surveillance on Consumer Rights Protection and Human …
Mass inoculation with the EpiVacCorona vaccine developed by Russia’s State Research Center of Virology and Biotechnology Vector will begin in the second half of March, the center’s Director General Rinat Maksyutov told Vesti news …
The EpiVacCorona coronavirus vaccine, developed by Russia’s State Research Center of Virology and Biotechnology Vector, has been approved for people over 60, the national consumer health watchdog said in a statement on Friday. …
